APA

de Witte M. A., Bendle G. M., van den Boom M. D., Coccoris M., Schell T. D., Tevethia S. S., van Tinteren H., Mesman E. M., Song J. & Schumacher T. N. M. (20081006). TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation. : Journal of immunology (Baltimore, Md. : 1950).

Chicago

de Witte Moniek A, Bendle Gavin M, van den Boom Marly D, Coccoris Miriam, Schell Todd D, Tevethia Satvir S, van Tinteren Harm, Mesman Elly M, Song Ji-Ying and Schumacher Ton N M. 20081006. TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation. : Journal of immunology (Baltimore, Md. : 1950).

Harvard

de Witte M. A., Bendle G. M., van den Boom M. D., Coccoris M., Schell T. D., Tevethia S. S., van Tinteren H., Mesman E. M., Song J. and Schumacher T. N. M. (20081006). TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation. : Journal of immunology (Baltimore, Md. : 1950).

MLA

de Witte Moniek A, Bendle Gavin M, van den Boom Marly D, Coccoris Miriam, Schell Todd D, Tevethia Satvir S, van Tinteren Harm, Mesman Elly M, Song Ji-Ying and Schumacher Ton N M. TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation. : Journal of immunology (Baltimore, Md. : 1950). 20081006.